Emerging Medicinal Chemistry of the YEATS4 Epigenetic Reader

YEATS4 (GAS41) is an acyllysine reader and a component of chromatin-remodelling complexes. Its amplification or overexpression in multiple malignancies, together with functional studies, link it to tumour growth. This has prompted efforts to develop YEATS4 ligands as chemical probes and potential anticancer agents. This review examines the structural basis of histone recognition by the YEATS4 YEATS domain and surveys the discovery, synthesis, structure–activity relationships, and biological evaluation of the ligands reported so far. We compare the thiophene-based monovalent and bivalent inhibitors, bicyclic heteroaryl–piperidine carboxamides, and emerging benzimidazole and arylthiophene series. Despite progress from fragment hits to potent ligands with cellular activity, YEATS4 inhibitor development is still at an early stage, with only a few inhibitor series reported to date and key challenges remaining.

Authors

Institutions

Publication Details

Journal
International Journal of Molecular Sciences
Published
2026-11-19
DOI
https://doi.org/10.3390/ijms272210429
Primary Topic
Protein Degradation and Inhibitors
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Emerging Medicinal Chemistry of the YEATS4 Epigenetic Reader

Piotr F. J. Lipiński, Jolanta Dyniewicz
International Journal of Molecular Sciences
Protein Degradation and Inhibitors
article

Emerging Medicinal Chemistry of the YEATS4 Epigenetic Reader

Piotr F. J. Lipiński, Jolanta Dyniewicz
article en

Abstract

YEATS4 (GAS41) is an acyllysine reader and a component of chromatin-remodelling complexes. Its amplification or overexpression in multiple malignancies, together with functional studies, link it to tumour growth. This has prompted efforts to develop YEATS4 ligands as chemical probes and potential anticancer agents. This review examines the structural basis of histone recognition by the YEATS4 YEATS domain and surveys the discovery, synthesis, structure–activity relationships, and biological evaluation of the ligands reported so far. We compare the thiophene-based monovalent and bivalent inhibitors, bicyclic heteroaryl–piperidine carboxamides, and emerging benzimidazole and arylthiophene series. Despite progress from fragment hits to potent ligands with cellular activity, YEATS4 inhibitor development is still at an early stage, with only a few inhibitor series reported to date and key challenges remaining.

International Journal of Molecular SciencesVol. 27(22)
Mossakowski Medical Research Institute, Polish Academy of Sciences (PL)
Protein Degradation and Inhibitors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon